Supplementary Fig. 11 from IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma

<jats:p>&lt;p&gt;Supplementary Figure 11. Spectral flow cytometry data from intracranial mouse glioblastoma allografts treated with combined IL6 and PD-1 blockade. Heatmap of T cell or myeloid cell subset frequencies from treated groups showing concordant changes with mass cytometry from Fig. 7, including suppression of Tregs, and enrichment in CD8+ T cells and cDCs with combined IL6 blockade and ICI compared to either IL6 inhibition or ICI treatment alone at T1 (n=3 samples/condition).&lt;/p&gt;</jats:p>